Introduction
The purpose of this communication is to draw attention to the apparently harmless hyperuricaemia which results from treating obese patients by total fasting.
In such patients there is a progressive fall in the glomerular filtration rate during the fasting period resulting in the renal retention of urate (Murphy & Shipman, 1964) . In addition there is competition between the ketone bodies and urate for the same, or a similar, renal transport mechanism (Cheifetz, 1965) ; this also results in the renal retention of urate. The resultant hyperuricaemia is on occasions gross, and has been associated with the acute joint disturbance typical of gout in a significant number of patients in the reported studies of Bloom (1959), Duncan, Frazer & Cristofori (1962) and Drenick et al. (1964) . Consequently, a history of gout in an obese patient has been accepted as being a strong contraindication to treatment by total fasting. Gilliland (1968) commenced probenecid therapy before the starvation period in patients with gout.
To date, we have studied forty-two obese patients treated by total fasting. The periods of observation ranged from a minimum of 3 weeks to 8 months, in the individual subject. Elevated levels of serum uric acid occurred in all, and in Table 1 Fig. 1 . From this, it can be seen that between the 5th and 9th days of fasting the serum uric acid rose from 4 to 15 mg/ 100 ml and remained above this latter value for a further 28 days. The patient was given a 400 calorie diet and the level of serum uric acid fell from to 13 mg/100 ml within 3 days. On discharge it was still elevated at 15 mg/100 ml.
Throughout this period he remained symptom free, losing in the process 23 lb (10-4 kg). On discharge from hospital, an 800 calorie diet was prescribed, and sulphinpyrazone in a dose of 100 mg three times a day.
Discussion
The relationship between hyperuricaemia and acute arthropathy is not a direct one. Asymptomatic hyperuricaemia is common in the relatives of gouty subjects. In sufferers from gout, relapse is associated with a rise in the level of serum uric acid and therapy designed to maintain a normal blood level of uric acid can prevent relapse. The acute joint disturbance typical of gout has been described in other conditions in which the serum uric acid is raised such as in some of the myeloproliferative disorders, in severe chronic renal failure and following prolonged thiazide diuretic therapy.
In this series five of the forty-two subjects fasted for more than 100 days and two of these for more than 200 days. The resultant hyperuricaemia did not precipitate an acute joint disturbance in any patient.
This was the more remarkable in the known gouty subject, whose serum uric acid exceeded 15 mg/100 ml for 28 days, attaining a maximum value of 30 mg/ 100 ml and who had been initially admitted to the wards in relapse with a serum uric acid of 8-8 mg/ 100 ml. The immunity ofthese patients to the harmful effects of hyperuricaemia is obvious but at present inexplicable.
It has been suggested that the acute joint disturbance of gout may be precipitated by rapid fluctuations in the levels of serum urate (MacLachlan & Rodman, 1967) . In these fasting obese patients fluctuating hyperuricaemia was invariable but the changes may have occurred too slowly to precipitate an attack; there is usually a sharp rise in serum urate in the first few days of fasting and a rapid fall when the patients are given food. This effect is clearly shown in the gouty subject (Fig. 1) .
Other workers (Gordon, Goldberg & Chosy, 1963; Duncan et al., 1963; Drenick et al., 1964) have reported a significant incidence of gout in their fasting, obese patients. The singular absence of such attacks in our patients led us to suggest that this was due to the known rarity of this disorder in the West of Scotland (Thomson, Runcie & Miller, 1966 
